PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease†,‡

Speliotes, Elizabeth K., Butler, Johannah L., Palmer, Cameron D., Voight, Benjamin F., Hirschhorn, Joel N.·2010·Hepatology

DOI 10.1002/hep.23768

Cited by (362)

Items 201–300 of 362

Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review
Yuting Diao, Juan Tang, Xuerong Wang, Wei Deng, Jing Yan Tang, Chunfang You · 2022 · Infectious Diseases and Therapy
Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD
Chaowapong Jarasvaraparn, Eduardo Vilar‐Gómez, Katherine P. Yates, Laura Wilson, Brent A. Neuschwander‐Tetri, Rohit Seth Loomba, Oscar W. Cummings, Miriam B. Vos, Stavra A. Xanthakos, Jeffrey B. Schwimmer et al. · 2023 · Clinical Gastroenterology and Hepatology
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients
Umberto Vespasiani Gentilucci, Paolo Gallo, Aldostefano Porcari, Simone Carotti, Giovanni Galati, Livia Piccioni, Antonio De Vincentis, Chiara Dell’Unto, Ferruccio Vorini, Sergio Morini et al. · 2016 · Scandinavian Journal of Gastroenterology
LinkedPNPLA3polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B
Qin Pan · 2015 · World Journal of Gastroenterology
PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes
Jean‐Michel Petit, Boris Guiu, David Masson, Laurence Duvillard, Valérie Jooste, P. Buffier, Benjamin Bouillet, Marie‐Claude Brindisi, Isabelle Robin, Philippe Gambert et al. · 2011 · Liver International
Association between the PNPLA3 I148M Polymorphism and Non-Alcoholic Fatty Liver Disease in the Uygur and Han Ethnic Groups of Northwestern China
Yuexin Zhang, Wen Cai, Jiangmei Song, Lei Miao, Bei Zhang, Qin Xu, Lijuan Zhang, Hua Yao · 2014 · PLoS ONE
Global analysis of A-to-I RNA editing reveals association with common disease variants
Oscar Franzén, Raili Ermel, Katyayani Sukhavasi, Rajeev Jain, Anamika Jain, Christer Betsholtz, Chiara Giannarelli, Jason Ciril Kovacic, Arno Ruusalepp, Josefin Skogsberg et al. · 2018 · PeerJ
Mechanisms of Simple Hepatic Steatosis
Scott C. Matherly, Puneet Puri · 2012 · Clinics in Liver Disease
Non-alcoholic fatty liver disease–a chronic disease of the 21st century
Peter P. Metrakos, Nilsson Tommy · 2017 · Journal of Biomedical Research
The common adiponutrin variant p.I148M does not confer gallstone risk but affects fasting glucose and triglyceride levels.
Marcin Jan Krawczyk, Frank Gruenhage, M Mahler, Simona Tirziu, Monica Acalovschi, Frank Lammert · 2011 · PubMed
Constitutional and functional genetics of human alcohol‐related hepatocellular carcinoma
Pierre Nahon, Jean‐Charles Nault · 2017 · Liver International
Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease
Graham F. Brady, Raymond Kwan, Peter Ulintz, Phirum Nguyen, Shirin Bassirian, Venkatesha Basrur, Alexey I. Nesvizhskii, Rohit Seth Loomba, M. Bishr Omary · 2017 · Hepatology
I148M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese population
Xiaohua Li, Qingchuan Zhao, Kaichun Wu, Daiming Fan · 2010 · Hepatology
Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD
Mette Munk Lauridsen, Kim Ravnskjær, Lise Lotte Gluud, Arun Jayant Sanyal · 2025 · Journal of Clinical Investigation
Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated by Diabetes: Pathophysiology and Emerging Therapies
Hisanori Goto, Toshinari Takamura · 2025 · Journal of Obesity & Metabolic Syndrome
The latest idea in NAFLD/NASH pathogenesis
Masafumi Ono, Nobuto Okamoto, Toshiji Saibara · 2010 · Clinical Journal of Gastroenterology
Genetics in liver disease: new concepts
Vincent Zimmer, Frank Lammert · 2011 · Current Opinion in Gastroenterology
The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis
Young‐Seon Mederacke, Martha Maria Kirstein, Anika Großhennig, Silke Marhenke, Frauke Metzler, Michael Peter Manns, Arndt Vogel, Ingmar Mederacke · 2020 · Alimentary Pharmacology & Therapeutics
PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection
Karolina Rembeck, Cristina Maglio, Martin Lagging, Peer Brehm Christensen, Martti A. Färkkilä, Nina Langeland, Mads Rauning Buhl, Court Pedersen, Kristine Mørch, Gunnar Norkrans et al. · 2012 · BMC Medical Genetics
Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
Umberto Vespasiani Gentilucci, Chiara Dell’Unto, Antonio De Vincentis, Andrea Baiocchini, Marco Delle Monache, Roberto Cecere, Adriano Maria Pellicelli, Valerio Giannelli, Simone Carotti, Giovanni Galati et al. · 2018 · Canadian Journal of Gastroenterology and Hepatology
Characterizing the Mechanism Behind the Progression of NAFLD to Hepatocellular Carcinoma
Pierre Nahon, Manon Allaire, Jean‐Charles Nault, Valérie Paradis · 2020 · Hepatic Oncology
PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease
Chi‐Ming Tai, Chih‐Kun Huang, Hung‐Pin Tu, Jau‐Chung Hwang, Chi‐Yang Chang, Ming‐Lung Yu · 2014 · Surgery for Obesity and Related Diseases
Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studies
Yan Mei Zhao, Wenli Zhao, Jingchao Ma, Maeda Toshiyoshi, Ye Zhao · 2023 · Medicine
Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study
Paraskevas Gkolfakis, Georgios Tziatzios, Gabriela Leite, Ioannis S. Papanikolaou, Elias Xirouchakis, Ioannis G. Panayiotides, Athanasios Karageorgos, María Jesús Villanueva-Millán, Ruchi Mathur, Stacy R. Weitsman et al. · 2023 · Microorganisms
Obesity Defined as Excess Storage of Inert Triglycerides – Do We Need a Paradigm Shift?
Thorkild I. A. Sørensen · 2011 · Obesity Facts
Genetic and non-genetic drivers of histological progression and regression in MASLD
Eduardo Vilar Gómez, Katherine P. Yates, David Erwin Kleiner, Cynthia A. Behling, Oscar W. Cummings, Laura Wilson, Tiebing Liang, Chaowapong Jarasvaraparn, Rohit Loomba, Jeffrey B. Schwimmer et al. · 2025 · Journal of Hepatology
Noninvasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?
Ahilan Arulanandan, Rohit Seth Loomba · 2015 · Current Hepatology Reports
New Perspectives in Pediatric Nonalcoholic Fatty Liver Disease: Epidemiology, Genetics, Diagnosis, and Natural History
Jae Sung Ko · 2019 · Pediatric Gastroenterology Hepatology & Nutrition
Treatment of non-alcoholic fatty liver disease with focus on emerging drugs
Giulio Marchesini, Simona Moscatiello, F. Agostini, Nicola Villanova, Davide Festi · 2011 · Expert Opinion on Emerging Drugs
PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease
Raffaella Tortora, Antonio Rispo, Anna Alisi, Nicola Imperatore, Annalisa Crudele, Francesca Ferretti, Valério Nobili, Luca Miele, Nicolò Gerbino, N. Caporaso et al. · 2018 · Nutrients
Genetic Variation I148M in Patatin-Like Phospholipase 3 Gene and Risk of Non-Alcoholic Fatty Liver Disease Among Filipinos
Michael O Baclig, Jingky Lozano-Kühne, Cynthia A. Mapua, Juliet L Gopez-Cervantes, Filipinas Florendo Natividad · 2014 · Europe PMC (PubMed Central)
Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients
Luca V. C. Valenti, Alessio Aghemo, Albert Friedrich Stättermayer · 2012 · Journal of Hepatology
The ubiquitin E3 ligase BFAR promotes degradation of PNPLA3
Avash Das, Haili Cheng, Yang Wang, Lisa N. Kinch, Guosheng Liang, Sen Hong, Helen H. Hobbs, Jonathan C. Cohen · 2024 · Proceedings of the National Academy of Sciences
Impact of IL28B, ITPA and PNPLA3 Genetic Variants on Therapeutic Outcome and Progression of Hepatitis C Virus Infection
Karolina Rembeck, Martin Lagging · 2015 · Pharmacogenomics
A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease
Michelle Thuy Nguyen, Andrew Lian, Frederick Timothy Guilford, Vishwanath Venketaraman · 2025 · Biomedicines
Genetic analysis of nonalcoholic fatty liver disease within a Caribbean–Hispanic population
Deborah Edelman, Harmit S. Kalia, Maria Delio, Mustafa A. Alani, Karthik Krishnamurthy, Mortadha Abd, Adam Auton, Tao Wang, Allan W. Wolkoff, Bernice E. Morrow · 2015 · Molecular Genetics & Genomic Medicine
The Association between Pediatric NAFLD and Common Genetic Variants
Giuseppina Rosaria Umano, Mariangela Martino, Nicola Santoro · 2017 · Children
Consumption of Alcoholic and Sugar-Sweetened Beverages is Associated with Increased Liver Fat Content in Middle-Aged Men and Women
Esther Winters-van Eekelen, Joline W. J. Beulens, Anouk Geelen, Vera B. Schrauwen‐Hinderling, Hildo J. Lamb, A. Roos, Frits Richard Rosendaal, Renée de Mutsert · 2018 · Journal of Nutrition
Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum
Federica Tavaglione, Giovanni Targher, Luca V. C. Valenti, Stefano Romeo · 2020 · Endocrinology Diabetes & Metabolism
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B
Rosa Zampino, Nicola Coppola, Grazia Cirillo, Adriana Boemio, Anna Grandone, Maria Stanzione, Nicolina Capoluongo, Aldo Marrone, Margherita Macera, Evangelista Sagnelli et al. · 2015 · Digestive Diseases and Sciences
PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age
Renáta Šenkeříková, Soňa Fraňková, Milan Jirsa, Miluše Kreidlová, Dušan Merta, Magdaléna Neřoldová, Klara Chmelova, Julius Špičák, Jan Šperl · 2019 · PLoS ONE
Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics
Simona Riccio, Rosa Melone, Caterina Vitulano, Pierfrancesco Guida, Ivan Maddaluno, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa · 2022 · World Journal of Clinical Pediatrics
Host Genetics Predict Clinical Deterioration in HCV-Related Cirrhosis
Lindsay Y. King, Kara B. Johnson, Hui Zheng, Lan Wei, Thomas M. Gudewicz, Yujin Hoshida, Kathleen E. Corey, Tokunbo Opeyemi Ajayi, Nneka N. Ufere, Thomas F. Baumert et al. · 2014 · PLoS ONE
Mitochondrial GpC and CpG DNA Hypermethylation Cause Metabolic Stress-Induced Mitophagy and Cholestophagy
Claudia Theys, Joe Ibrahim, Ligia Monica Mateiu, Archibold Mposhi, Laura García-Pupo, Tim De Pooter, Peter De Rijk, Mojca Stražišar, İkbal Agah İnce, Iuliana Vintea et al. · 2023 · International Journal of Molecular Sciences
Integrating PNPLA3 into clinical risk prediction
Vincent Lingzhi Chen, Umberto Vespasiani Gentilucci · 2024 · Liver International
Emerging Genes Associated with the Progression of Nonalcoholic Fatty Liver Disease†,‡
Christina Koutsari, Konstantinos N. Lazaridis · 2010 · Hepatology
Interaction of SAMM50-rs738491 , PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis
Ke Xu, Kenneth I. Zheng, Pei‐Wu Zhu, Wen‐Yue Liu, Hong‐Lei Ma, Gang Li, Liang‐Jie Tang, Rafael S. Rios, Giovanni Targher, Christopher D. Byrne et al. · 2021 · Journal of Clinical and Translational Hepatology
Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosis
Jessica Seeßle, Hongying Gan‐Schreier, Marietta Kirchner, Wolfgang Stremmel, Waleé Chamulitrat, Uta Merle · 2020 · BMC Gastroenterology
TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion
Joanne Hsieh, Matthew M. Molusky, Kristin M. McCabe, Panagiotis Fotakis, Tong Xiao, Liana Tascau, Lars Zeana-Schliep, Paul A DaSilva-Jardine, Alan R. Tall · 2021 · Journal of Hepatology
Ethnic differences in the effects of hepatic fat deposition on insulin resistance in nonobese middle school girls
Peter M. Wolfgram, Ellen Lancon Connor, Jennifer L. Rehm, Jens C. Eickhoff, Scott Brian Reeder, David B. Allen · 2013 · Obesity
Is Nonalcoholic Fatty Liver Disease in Children the Same Disease as in Adults?
Evelyn Kanyu Hsu, Karen F. Murray · 2012 · Clinics in Liver Disease
Relationship between N,N-dimethylformamide exposure, PNPLA3, GCKR, COL13A1 and TM6SF2 genes, and liver injury
Xiaoyue Zhang, Haiyue Jiang, Jiayang Shen, Yu Zhang, Yiyang Gu, Jing Xiao, Yulong Lian · 2019 · Ecotoxicology and Environmental Safety
The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study
Wen Dai, Ziyu Zhang, Shui‐Ping Zhao · 2021 · Frontiers in Cardiovascular Medicine
Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?
Margaret Morrison, Heather Hughes, Susanna Naggie, Wing‐Kin Syn · 2019 · Digestive Diseases and Sciences
The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu
Hans Dieter Nischalke, Philipp Ludwig Lutz, Eva Bartok, Benjamin Krämer, Bettina Langhans, Regina Frizler, Thomas Berg, Jochen Hampe, Stephan Buch, Christian Datz et al. · 2019 · Journal of Molecular Medicine
Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients
Oana Irina Gavril, Lidia Iuliana Arhire, Radu Sebastian Gavril, Ioana Mădălina Zota, Andreea Gherasim, Otilia Niță, Andrei Drugescu, Andrei Cătălin Oprescu, Irina Eşanu, Florin Mitu et al. · 2021 · Medicina
Nonalcoholic Fatty Liver Disease in Pediatrics
Martin Duncan, Wenjing Zong, Vincent Biank, Joseph R. Hageman · 2016 · Pediatric Annals
Association between rs738408, rs738409 and rs139051polymorphisms in PNPLA3 gene and non-alcoholic fatty liver disease
Mojtaba Najafi, Alireza Rafiei, Alireza Ghaemi, Vahid Hosseini · 2022 · Gene Reports
PNPLA3 and TNF-α G238A Genetic Polymorphisms in Egyptian Patients with Different Grades of Severity of NAFLD
Mona Hegazy, Rasha M. Abdel Samie, Ahmed A. Ezzat, Nagwa Mahmoud Ramadan, Laila Ahmed Rashed, Abeer Mostafa Elsayed · 2016 · Open Journal of Gastroenterology
Association between rs738409 and rs2896019 single nucleotide polymorphisms of phospholipase domain-containing protein 3 and susceptibility to nonalcoholic fatty liver disease in Greek children and adolescents
Eleanna Stasinou · 2022 · Annals of Gastroenterology
Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries
Hilmar Klaus Luckhoff · 2015 · World Journal of Hepatology
Genetic Variants in the PNPLA3 Gene Are Associated with Nonalcoholic Steatohepatitis
Eylül Ece İşlek, Ali Sazcı, Mavi Deniz Ozel, Cem Aygün · 2014 · Genetic Testing and Molecular Biomarkers
A tool to predict progression of non‐alcoholic fatty liver disease in severely obese patients
Pierre Bauvin, Claire Delacôte, Guillaume Lassailly, Line Carolle Ntandja Wandji, Viviane Gnemmi, Flavien Dautrecque, Alexandre Louvet, Robert J. Caiazzo, Violeta Raverdy, Emmanuelle Leteurtre et al. · 2020 · Liver International
Factors associated with elevated alanine aminotransferase in employees of a German chemical company: results of a large cross-sectional study
Matthias Claus, Christoph Antoni, Bernd Hofmann · 2021 · BMC Gastroenterology
Frequency of the PNPLA3 rs738409 polymorphism and other genetic loci for liver disease in a Guatemalan adult population
Mariana Lazo, Jiaqi Xie, Christian S. Álvarez, Dominick Parisi, Stephanie Y. Yang, Alvaro Rivera‐Andrade, Maria Fernanda Kroker-Lobos, John D. Groopman, Eliseo Güallar, Manuel Ramírez‐Zea et al. · 2022 · Liver International
Nonalcoholic Fatty Liver Disease: A Pathological View
Joaquín Cabezas, Marta María Mayorga, Javier Crespo · 2012 · InTech eBooks
Isoleucine-to-methionine substitution at residue 148 variant of PNPLA3 gene and metabolic outcomes in gestational diabetes
Simona Bo, Roberto Gambino, Guido Menato, S. Canil, Valentina Ponzo, Silvia Pinach, Marilena Durazzo, Ezio Ghigo, Maurizio Cassader, Giovanni Musso · 2014 · American Journal of Clinical Nutrition
Association of PNPLA3 rs738409 polymorphism with liver steatosis but not with cirrhosis in patients with HBV infection: Systematic review with meta‐analysis
Saman Ghalamkari, Heidar Sharafi, Seyed Moayed Alavian · 2017 · The Journal of Gene Medicine
The effect of PNPLA3 polymorphism as gain in function mutation in the pathogenesis of non-alcoholic fatty liver disease
Anıl Delik, Hikmet Akkız, Sadık Dinçer · 2020 · Indian Journal of Gastroenterology
APOC3 polymorphisms and non-alcoholic fatty liver disease: Resolving some doubts and raising others
Manuel Romero‐Gómez · 2011 · Journal of Hepatology
Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1
Basel Aldroubi, John A. Najjar, Tya Youssef, C. Rizk, Basil A. M. Abuamreh, Karl Aramouni, Hilda E. Ghadieh, Sonia Michael Najjar · 2024 · Metabolism and Target Organ Damage
Sex Differences in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Epidemiology, Pathophysiology, and Clinical Implications
Kanica Kaushal, Smriti Singh, Ankita Anand, Gayatri Ramakrishna, Pratibha Ramchandra Kale, Rishabh Sharma, Bharat Bhushan Rewari, Shiv Kumar Sarin · 2026 · Journal of Clinical and Experimental Hepatology
Molecular mechanisms of liver carcinogenesis related to metabolic syndrome
C. Campani, J. Nault · 2022 · Hepatoma Research
Association study of PNPLA2 gene with histological parameters of NAFLD in an obese population
Doreen Zegers, An Verrijken, Sigri Beckers, Sven Francque, Jasmijn K. Van Camp, Evi Aerts, Martin Ruppert, Guy Hubens, Peter P. Michielsen, Wim Van Hul et al. · 2015 · Clinics and Research in Hepatology and Gastroenterology
A comprehensive evaluation of candidate genetic polymorphisms in a large histologically characterized MASLD cohort using a novel framework
Aaron Hakim, Kung-Hung Lin, Tae-Hwi Linus Schwantes-An, Marco Abreu, Jingyi Tan, Xiuqing Guo, Katherine P. Yates, Luca Andrea Lotta, Niek Verweij, Rohit Seth Loomba et al. · 2025 · Hepatology Communications
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application
Vincent Lingzhi Chen, Graham F. Brady · 2025 · Hepatology Communications
Healthy PNPLA3 Risk Allele Carriers Present with Unexpected Body Fat Composition. A Study of One ousand Subjects
Agnieszka Kempińska‐Podhorodecka, Marcin Jan Krawczyk, Marta Klak, Małgorzata Blatkiewicz, Frank Lammert, Piotr Milkiewicz, Małgorzata Milkiewicz · 2014 · Journal of Gastrointestinal and Liver Diseases
Role of genetics in diagnosis and therapy of acquired liver disease
Vincent Zimmer, Frank Lammert · 2013 · Molecular Aspects of Medicine
Fish to meat intake ratio and cooking oils are associated with hepatitis C virus carriers with persistently normal alanine aminotransferase levels
Momoka Otsuka, Yuki Uchida, Takumi Kawaguchi, Eitaro Taniguchi, Atsushi Kawaguchi, Shingo Kitani, Minoru Itou, Tetsuharu Oriishi, Tatsuyuki Kakuma, Suiko Tanaka et al. · 2012 · Hepatology Research
Type 2 Diabetes, PNPLA3 rs738409 Polymorphism, and the Risk of Liver Cirrhosis: Analysis of Taiwan Biobank
Kuan‐Chun Hsueh, Oswald Ndi Nfor, Shu‐Yi Hsu, Shun‐Fa Yang, Yung‐Po Liaw · 2022 · Frontiers in Genetics
Association of rs738409 Polymorphism in Adiponutrin Gene with Liver Steatosis and Atherosclerosis Risk Factors in Greek Children and Adolescents
Eleanna Stasinou, Elpida Emmanouilidou-Fotoulaki, Maria Kavga, Fotini Sotiriadou, Alexandros F. Lambropoulos, Maria Fotoulaki, Kyriaki Papadopoulou‐Legbelou · 2022 · Nutrients
Responsiveness of PNPLA3 and lipid-related transcription factors is dependent upon fatty acid profile in primary bovine hepatocytes
Sophia J. Erb, Tawny L. Chandler, Heather M. White · 2022 · Scientific Reports
Clinical Epidemiology of NAFLD
Donghee Kim, Osama Siddique, Brandon J. Perumpail, Aijaz Ahmed · 2018 · Springer eBooks
Understanding the relationship between PNPLA 3, NAFLD and insulin resistance: do ethnic differences bring more questions or more answers?
Charissa Chang · 2011 · Liver International
Genetic Risk of MASLD in Mongolians: Role of PNPLA3 and FTO SNPs
Yumchinsuren Tsedendorj, Dolgion Daramjav, Yesukhei Enkhbat, Ganchimeg Dondov, Gantogtokh Dashjamts, Enkhmend Khayankhyarvaa, Amin-Erdene Ganzorig, Bolor Ulziitsogt, Tegshjargal Badamjav, Batbold Batsaikhan et al. · 2025 · Current Issues in Molecular Biology
TM6SF2-rs58542926 Genetic Variant Modifies the Protective Effect of a “Prudent” Dietary Pattern on Serum Triglyceride Levels
Ioanna Panagiota Kalafati, Maria Dimitriou, Konstantinos Revenas, Alexander D. Kokkinos, Panos Deloukas, George V. Dedoussis · 2023 · Nutrients
The health care experience of adults with metabolic dysfunction–associated steatohepatitis and influence of PNPLA3: A qualitative study
Jonathan G. Stine, Nenad Medić, Billie Pettersson, Meredith Venerus, Jenny E. Blau · 2024 · Hepatology Communications
Metabolic oxidation controls the hepatic stem cells (HpSCs) fate and the hepatic lineage organization in physiologic and pathologic conditions
Vincenzo Cardinale, Guido Carpino, Alfredo Cantàfora, Lola McAdams Reid, Eugenio Gaudio, Domenico Alvaro · 2012 · Hepatology
I148M variant of PNPLA3-gene is not associated with metabolic syndrome in patients with NAFLD in the Indian ethnicity
Govardhan Bale, Mitnala Sasikala, Nagaraja Rao Padaki, Mithun Sharma, Anand V. Kulkarni, Smita C. Pawar, Nageshwar Reddy D, Ravikanth Vishnubhotla · 2022 · Human Gene
I148M PNPLA3 Variant and Progressive Liver Disease: A New Paradigm in Hepatology
Luca V. C. Valenti, Anna Alisi, Valério Nobili · 2011 · Hepatology · Retracted
Association of PNPLA3 (rs738409 C>G) with Liver Damage in Liver Diseases: One Step Closer to Personalized Medicine?
Eric Trépo, Denis Paul Franchimont, Christophe Moreno · 2011 · Personalized Medicine
Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort study
Julia Kozlitina, Naomi M Cohen, Drew Sturtevant, Jonathan C. Cohen, Cathi Murphey-Half, Jerome G. Saltarrelli, Peter Jindra, Medhat Z. Askar, Christine S. Hwang, Parsia A. Vagefi et al. · 2023 · EClinicalMedicine
The effect of cetrorelix vs. ganirelix on pregnancy outcome using minimal gonadotropin stimulation in women with elevated day 3 serum follicle stimulating hormone levels.
J H Check, D. Brasile, Choe Jk, J. Amui, C Wilson · 2009 · PubMed
Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non‐alcoholic fatty liver disease
Jane I. Grove, Prarthana Thiagarajan, Stuart Astbury, Rebecca Harris, Toby Delahooke, Indra Neil Guha, Guruprasad Padur Aithal · 2018 · Liver International
PNPLA3 L148M (rs738409) polymorphism as a risk for new onset diabetes mellitus and obesity in non-NASH/cryptogenic living related donor liver transplant recipients
Osama Desouky Elbahr, Amany A. Saleh, Lamiaa H. Bakery · 2020 · Gene Reports
Nonalcoholic Fatty Liver Disease
Emer Fitzpatrick · 2015 · Springer eBooks
Suppressed Fat Mobilization Due to PNPLA3 rs738409 -Associated Liver Damage in Heavy Drinkers: The Liver Damage Feedback Hypothesis
Vanessa Rausch, Sebastian Mueller · 2018 · Advances in experimental medicine and biology
Fatty Liver, NASH, and Alcoholic Liver Disease
M. Shimada, Jianfeng Cheng, Arun Jayant Sanyal · 2014 · Elsevier eBooks
Hepatic patatin-like phospholipase domain-containing protein 3 sequence, single nucleotide polymorphism presence, protein confirmation, and responsiveness to energy balance in dairy cows
Christine McCann, Molly E. Viner, Shawn Scott Donkin, Heather Muse White · 2014 · Journal of Dairy Science
Insights into paediatric non‐alcoholic fatty liver disease from genetic variants
Jiawen Dong, Yu Ri Im, Jake Peter Mann · 2019 · Liver International